Balance Sheet Data

Novavax, Inc. (NVAX)

$17.24

+0.02 (+0.12%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 157.3092.1378.82711.051,515.1225,011.40184,703.781,363,997.5210,072,826.9874,385,650.68
Total Cash (%)
Account Receivables --7.50262.01454.993,808.5228,125.07207,697.571,533,801.6611,326,793.86
Account Receivables (%)
Inventories 13.0811.977.17182.85440.713,254.5524,034.12177,486.761,310,701.389,679,246.51
Inventories (%)
Accounts Payable 5.619.302.9154.33127.051,409.1210,406.0476,846.35567,493.664,190,818.07
Accounts Payable (%)
Capital Expenditure -4.19-1.37-1.86-54.62-57.49-743.04-5,487.21-40,521.87-299,245.27-2,209,861.67
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.